Rocket Pharmaceuticals Income Statement (2016-2025) | RCKT

1Y3Y5Y7Y10YAll
Download Data
Income Statement Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Revenue & cost
Revenue -0.21M-0.53M0.21M-1.41M-1.36M-1.18M-2.03M-1.60M-1.54M-1.47M-1.34M-1.57M-1.79M-1.97M-1.64M-1.73M-0.25M-0.53M-0.46M-0.46M-0.47M-0.47M-0.47M-0.47M-0.47M-0.47M-0.47M-0.47M-0.47M-0.47M-0.47M-0.47M-0.47M-0.47M
Operating items
Amortization - Intangibles 0.01M0.80M0.25M0.32M0.37M0.24M0.06M-0.12M-0.24M-0.27M-0.64M-0.73M-0.74M-0.80M-0.58M-0.40M-0.16M1.08M2.42M2.68M2.28M3.27M2.76M2.24M1.85M1.22M2.19M2.22M1.68M
Research & Development 7.62M8.41M6.46M2.29M2.82M4.89M4.92M5.74M10.77M13.06M23.68M15.14M13.99M14.83M13.95M16.96M16.73M21.66M50.09M28.31M24.53M39.62M33.02M30.79M41.36M43.38M50.04M46.37M51.38M46.84M41.74M45.23M46.34M42.31M37.36M35.94M42.66M34.07M
Selling, General & Administrative 2.52M2.31M2.31M0.58M0.70M1.83M1.74M8.66M4.10M2.27M2.87M3.81M4.40M4.34M5.70M7.16M6.83M5.73M9.14M10.91M9.52M10.03M11.32M11.77M12.85M15.11M19.05M15.82M17.37M18.59M21.54M22.15M27.37M27.11M25.34M28.45M25.02M18.35M
Restructuring Costs -0.17M
Other Operating Expenses -15.67M-35.76M-16.00M-0.01M-0.04M-78.22M-0.00M3.47M
Operating Expenses 10.14M10.72M8.78M2.87M3.52M6.72M6.66M14.40M14.87M15.33M26.55M18.95M18.39M19.16M19.65M24.12M23.56M27.39M59.24M39.22M34.05M49.65M44.33M42.56M54.21M58.49M69.08M62.19M68.76M65.43M63.28M67.38M73.71M69.42M62.69M64.39M71.15M52.25M
Operating Income -10.14M-10.72M-8.78M-2.87M-3.52M-6.72M-6.66M-14.40M-14.87M-15.33M-26.55M-18.95M-18.39M-19.16M-19.65M-24.12M-23.56M-27.39M-59.24M-39.22M-34.05M-49.65M-44.33M-42.56M-54.21M-58.49M-69.08M-62.19M-68.76M-65.43M-63.28M-67.38M-73.71M-69.42M-62.69M-64.39M-71.15M-52.25M
EBIT -10.14M-10.72M-8.78M-2.87M-3.52M-6.72M-6.66M-14.40M-14.87M-15.33M-26.55M-18.95M-18.39M-19.16M-19.65M-24.12M-23.56M-27.39M-59.24M-39.22M-34.05M-49.65M-44.33M-42.56M-54.21M-58.49M-69.08M-62.19M-68.76M-65.43M-63.28M-67.38M-73.71M-69.42M-62.69M-64.39M-71.15M-52.25M
Non-operating items
Interest & Investment Income 0.07M0.12M0.10M0.00M0.29M0.47M0.42M0.45M0.60M0.94M0.98M0.89M0.97M0.43M0.52M0.24M0.91M0.50M0.81M0.85M0.62M0.67M1.35M1.25M1.91M0.85M1.72M0.81M3.03M2.29M1.33M1.62M1.34M0.48M0.71M
Net income details
EBT -10.28M-11.13M-8.47M-2.87M-3.52M-6.72M-6.66M-15.54M-15.77M-16.09M-28.12M-19.95M-19.00M-19.65M-20.10M-24.73M-24.92M-28.84M-60.64M-40.04M-33.80M-49.37M-43.95M-42.41M-54.01M-57.60M-68.30M-60.75M-68.38M-64.18M-62.94M-64.82M-71.89M-68.57M-61.55M-63.52M-71.14M-52.01M
Profit After Tax -10.07M-11.13M-8.68M-2.68M-3.52M-6.72M-6.66M-15.34M-15.77M-16.09M-27.32M-19.45M-18.68M-19.28M-19.86M-24.66M-25.04M-29.08M-60.92M-40.18M-34.52M-50.12M-44.25M-42.98M-54.40M-57.76M-66.72M-58.34M-65.70M-61.90M-59.66M-62.05M-69.65M-66.72M-60.33M-61.33M-68.92M-50.33M
Income from Continuing Operations -10.28M-11.13M-8.47M-2.87M-3.52M-6.72M-6.66M-15.54M-15.77M-16.09M-28.12M-19.95M-19.00M-19.65M-20.10M-24.73M-24.92M-28.84M-60.64M-40.04M-33.80M-49.37M-43.95M-42.41M-54.01M-57.60M-68.30M-60.75M-68.38M-64.18M-62.94M-64.82M-71.89M-68.57M-61.55M-63.52M-71.14M-52.01M
Consolidated Net Income -10.28M-11.13M-8.47M-2.87M-3.52M-6.72M-6.66M-15.54M-15.77M-16.09M-28.12M-19.95M-19.00M-19.65M-20.10M-24.73M-24.92M-28.84M-60.64M-40.04M-33.80M-49.37M-43.95M-42.41M-54.01M-57.60M-68.30M-60.75M-68.38M-64.18M-62.94M-64.82M-71.89M-68.57M-61.55M-63.52M-71.14M-52.01M
Income towards Parent Company -10.28M-11.13M-8.47M-2.87M-3.52M-6.72M-6.66M-15.54M-15.77M-16.09M-28.12M-19.95M-19.00M-19.65M-20.10M-24.73M-24.92M-28.84M-60.64M-40.04M-33.80M-49.37M-43.95M-42.41M-54.01M-57.60M-68.30M-60.75M-68.38M-64.18M-62.94M-64.82M-71.89M-68.57M-61.55M-63.52M-71.14M-52.01M
Net Income towards Common Stockholders -10.28M-11.13M22.31M-2.68M-3.33M-6.72M-6.66M-15.34M-15.77M-16.09M-27.32M-19.95M-19.00M-19.65M-20.10M-24.66M-25.04M-29.08M-60.92M-40.18M-34.52M-50.12M-44.25M-42.98M-54.40M-57.76M-66.72M-58.34M-65.70M-61.90M-59.66M-62.05M-69.65M-66.72M-60.33M-61.33M-68.92M-50.33M
Additional items
EPS (Basic) -0.38-0.41-0.33-0.39-0.49-0.99-0.98-0.42-0.40-0.40-0.66-0.43-0.38-0.38-0.39-0.45-0.45-0.53-1.09-0.65-0.55-0.79-0.68-0.67-0.83-0.87-0.89-0.73-0.82-0.75-0.62-0.66-0.74-0.71-0.62-0.56-0.62-0.45
EPS (Weighted Average and Diluted) -0.41-0.45-0.45-0.53-1.09-0.65-0.55-0.79-0.68-0.67-0.83-0.87-0.89-0.73-0.82-0.75-0.62-0.66-0.74-0.71-0.62-0.56-0.62-0.45
Shares Outstanding (Weighted Average) 6.61M6.61M6.73M6.73M6.75M6.75M6.75M6.81M39.40M39.48M39.66M39.84M45.11M50.29M50.35M50.38M55.07M55.16M55.19M55.23M61.78M63.40M63.62M64.44M64.51M65.84M66.04M75.68M79.35M80.46M80.53M90.16M90.50M90.78M90.98M91.16M106.63M107.74M107.90M
Shares Outstanding (Diluted Average) 49.01M54.88M55.16M55.19M55.38M61.57M63.06M63.83M63.24M64.51M65.48M66.22M68.15M79.45M80.47M82.64M84.01M93.55M93.76M94.16M94.81M110.09M111.02M111.57M
EBITDA -10.14M-10.72M-8.78M-2.87M-3.52M-6.72M-6.66M-14.40M-14.87M-15.33M-26.55M-18.95M-18.39M-19.16M-19.65M-24.12M-23.56M-27.39M-59.24M-39.22M-34.05M-49.65M-44.33M-42.56M-54.21M-58.49M-69.08M-62.19M-68.76M-65.43M-63.28M-67.38M-73.71M-69.42M-62.69M-64.39M-71.15M-52.25M
Interest Expenses 0.21M0.53M-0.21M1.43M1.36M1.18M2.03M1.60M1.54M1.47M1.34M1.57M1.79M1.97M1.64M1.73M0.25M0.53M0.46M0.46M0.47M0.47M0.47M0.47M0.47M0.47M0.47M0.47M0.47M0.47M0.47M0.47M0.47M0.47M